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‘ ’
Tackling cancer is of fundamental importance 
for our future. If we join forces at EU level 
we can make a difference and reduce the 
suffering of cancer in Europe.
Stella Kyriakides, 
European Commissioner 
for Health and Food Safety 
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WHAT IS ECIBC? 
In 2008 the European Parliament and Council gave strate-
gic directions to future European activities on combatting 
cancer, and sought to further support Member States in 
their efforts to reduce the burden of this disease. Particular 
attention was given to the most frequent cancers. This 
led, among other things, to the European Commission 
Initiative on Breast Cancer (ECIBC).
ECIBC addresses the need to improve the quality of breast 
cancer care across Europe, from screening and diagnosis 
to treatment and palliative care. 
This is achieved through developing and providing 
evidence-based recommendations for breast cancer 
screening and diagnosis (European Guidelines) and a 
voluntary quality assurance scheme (QA Scheme) for 
breast cancer early detection and care. In addition, useful 
information and tools for breast cancer services, health-
care professionals and women will be made available. 
All ECIBC products are publicly available and free to 
access on the ECIBC website.1
1 ECIBC Internet address: healthcare-quality.jrc.ec.europa.eu
AN INITIATIVE  
TO TACKLE 
BREAST CANCER 
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HOW IS THE INITIATIVE IMPLEMENTED? 
The ECIBC quality assurance scheme defines a common 
set of requirements for breast cancer services covering 
all stages of care. It is for voluntary application but those 
services seeking certification must meet all the require-
ments outlined in the QA Scheme.
The European Guidelines provide evidence-based recom-
mendations for screening and diagnosis, and inform the 
development of the ECIBC quality assurance scheme.
Healthcare authorities and professionals can adopt the 
European Guidelines as they are provided, or adapt them 
to their local context through a transparent process made 
available by ECIBC.
WHY IS THERE A NEED FOR THIS INITIATIVE? 
Breast cancer is a cross-border issue that affects women 
of all ages, and inequalities in healthcare delivery in this 
area persist. Every woman in Europe should have the 
right to access quality breast cancer services, regardless 
of where she lives or her financial resources. 
Coordinated action at the European level for the quality 
assurance of breast cancer care will contribute towards 
ensuring that women across Europe have access to opti-
mal healthcare based on the latest available evidence.
WHO WILL BENEFIT? 
ECIBC activities will ultimately benefit women. By ensur-
ing an essential level of quality of breast cancer services 
with a person-centred perspective, the initiative aims to 
help reduce inequalities in healthcare delivery, empower-
ing women and improving their quality of life and survival. 
Women, patients and their families can access the 
latest European Guidelines on breast cancer screening 
and diagnosis developed by the ECIBC initiative also in 
plain language formulated for non-professional public. 
Additionally, specific tools are being developed to help 
make decisions that are more informed.  
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KEY FEATURES
• Evidence-based recommendations for screening 
and diagnosis
• Available online and regularly updated 
• Targeted to address professionals, women and 
policy makers
ECIBC has developed evidence-based practice guide-
lines for breast cancer screening and diagnosis including 
recommendations intended to optimise patient care. Each 
recommendation, publicly available on the ECIBC website, 
contains information specifically tailored to women and 
healthcare professionals, as well as decision-makers. 
The recommendations in the European Guidelines:
• are based on systematic reviews of existing evidence 
conducted by an independent team;
• have been developed by a knowledgeable, multi-
disciplinary panel of experts, namely the Guideline 
Development Group (GDG); 
• take into account patient needs; 
• follow a transparent process that minimises conflicts 
of interest;
• provide a clear explanation of care options, including 
their benefits and harms;
EUROPEAN 
GUIDELINES
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• rate both the quality of the evidence and the strength 
of the recommendation; 
• are revised when important new evidence comes to 
light. 
The recommendations, freely accessible from the ECIBC 
website, are grouped into three main topics (see table 
below).
Each sub-topic includes one or more recommendations 
presented in a question and answer format. The strength 
of each recommendation is qualified as ‘strong’ or ‘condi-
tional’ based on an analysis of the evidence available. 
• A strong recommendation means that most people 
in this situation would want and should receive the 
recommended course of action and only a small 
proportion would not, and that the recommendation 
can be adapted as a policy in most situations.
• A conditional recommendation means that the 
majority of people in this situation would want the 
recommended course of action, but many would not. 
Clinicians should be prepared to help patients make a 
decision that is consistent with their own values, and 
for policy makers, a substantial debate is needed that 
involves stakeholders.
E
C
IB
C
 A
T
 A
 G
L
A
N
C
E
 E
U
R
O
P
E
A
N
 C
O
M
M
IS
S
IO
N
 IN
IT
IA
T
IV
E
 O
N
 B
R
E
A
S
T
 C
A
N
C
E
R
| 9
  
  
  
  
  
 
WHAT DO THE EUROPEAN GUIDELINES LOOK LIKE? 
Each recommendation in the European Guidelines is 
organised, for example, as follows:
1. Healthcare question
Should organised mammography screening versus no 
mammography screening be used for early detection 
of breast cancer in women aged 40 to 44?
2. Final recommendation
For asymptomatic women aged 40 to 44 with an 
average risk of breast cancer, the ECIBC’s Guidelines 
Development Group (GDG) suggests not implement-
ing mammography screening.
3. Strength of the recommendation 
• Conditional recommendation against the intervention.
• Moderate certainty of the evidence.
4. Considerations on specific population sub-groups
This recommendation does not apply to high-risk 
women. 
5. Considerations for implementation and policy 
making
GDG members agreed on the need for additional imag-
ing techniques in this age group, as well as the need 
for shared decision making.
6. Monitoring and evaluation of the recommendation
Future monitoring and evaluation of screening services 
should consider benefits and risks in the context of 
evolving treatment and management protocols.
7. Research priorities, if identified:
• Carry out evaluations of the efficacy of the inter-
vention, time intervals, risk factors and stratification of 
women, as well as context specific cost-effectiveness 
in this age group.
• Carry out studies addressing the role of other 
screening modalities (such as magnetic resonance 
imaging – MRI) in this population.
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8. Supporting documents
• Evidence to Decision: recommendation justifications, 
considerations and assessments.
• Evidence Profile: Quality assessments of the 
evi dence from literature reviews and a summary of 
findings.
• Bibliography.
9. Summary information for women
This section includes the recommendation itself; what 
following this recommendation means; who the recom-
mendation is for; as well as definitions and additional 
considerations for further clarification.
UPDATING STRATEGY 
The European Guidelines are regularly monitored and 
updated as and when new scientific evidence becomes 
available. This makes the process time- and cost-efficient. 
Some recommendations are likely to need more frequent 
updates than others, such as those related to new inno-
vative technologies or rapidly evolving scientific fields. 
The updating process allows the consideration of new 
evidence, which may impact recommendations. The process 
is modular and subdivided into phases, to assess specific 
updating needs for each recommendation.
The four phases of the updating strategy consist of:
i) prioritisation; 
ii) surveillance; 
iii) updating; and 
iv) publication. 
Each recommendation can go through one or more of 
these phases depending on the new evidence available. 
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REPOSITORY OF 
INTERNATIONAL 
GUIDELINES 
KEY FEATURES
• Library of guidelines from around the world
• Includes treatment, rehabilitation, follow-up  
and palliative care 
• Inform the ECIBC quality assurance scheme 
Breast cancer guidelines are published by numerous insti-
tutions and organisations across the world. Healthcare 
professionals can find it challenging to identify and imple-
ment guidelines for specific breast cancer care processes. 
This repository of current international guidelines on breast 
cancer complements the European Guidelines on screen-
ing and diagnosis. These guidelines were assessed for their 
quality, clinical impact, geographical coverage and sustain-
ability, and have been published within the past 10 years. 
They cover prevention of breast cancer, treatment, reha-
bilitation, follow-up and survivorship, palliative care and 
end-of-life care. Additionally, they provide underpinning 
evidence for the European quality assurance scheme, 
addressed in the next chapter.
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KEY FEATURES
• Quality, safety and training requirements for 
breast cancer services and professionals
• From organised population-based screening  
to end-of-life care 
• Voluntary, flexible and modular implementation
The ECIBC quality assurance scheme (QA Scheme) defines 
a common set of quality and safety requirements for breast 
cancer services in Europe, as well as training requirements 
for professionals involved in breast cancer care. It focuses 
on aspects that are relevant to citizens and patients, and 
covers all the relevant care processes from screening until 
the end-of-life care. 
The QA scheme will be freely available to all interested 
breast cancer services (e.g. hospitals, clinics, diagnostic 
centres, etc.) worldwide. 
THE QUALITY  
ASSURANCE 
SCHEME 
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The requirements contained in the scheme are definable, 
measurable and actionable. They relate directly to the main-
tenance, restoration or improvement of health, and relate 
to one or more of the following quality domains:
• clinical effectiveness;
• facilities, resources and workforce;
• personal empowerment and experience;
• safety.
Breast cancer screening and care involves different health-
care services, depending on the individual course of the 
disease. The breast cancer pathway defined and covered 
by the scheme shows the journey followed by a patient, 
including possible entry and end points and the services 
involved.
Breast cancer care pathway covered by the QA Scheme
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were formulated in areas where the expert group identi-
fied a need for quality improvement.
Requirements were prioritised and first rated for: i) rele-
vance and understandability, and then for ii) feasibility. 
Relevance relates to the significance of the requirements 
for a person-oriented care. Feasibility relates to the abil-
ity of the requirements to be implemented.
IMPLEMENTING THE QA SCHEME 
The QA Scheme aims to support quality breast cancer 
care across Europe and to decrease inequalities in care 
and survival. Implementation of the QA Scheme is volun-
tary. The initiative has been developed in a flexible way, 
adaptable to national contexts. 
The QA Scheme adheres to evidence-based guidelines, 
and this has been linked with achieving better health 
outcomes.  
Certification 
Breast cancer services that fulfil the quality assurance 
requirements can be certified. This certification covers the 
entire breast cancer care pathway as defined by ECIBC. 
REQUIREMENTS
The scheme includes a list of requirements for breast 
cancer services addressing the quality of care. Each 
requirement comprises: i) a statement, ii) detailed infor-
mation on what is measured and how, and iii) provides 
the corresponding supporting evidence and references. 
Breast cancer services that fulfil the QA Scheme require-
ments will obtain a recognised certificate. 
The QA Scheme is based on evidence coming from recom-
mendations from the European Guidelines on screening 
and diagnosis, as well as the repository of international 
guidelines. 
DEVELOPING THE QUALITY ASSURANCE SCHEME
The QA Scheme is the result of cooperative work. The 
Quality Assurance Scheme Development Group (QASDG) 
brought together a panel of international professional 
experts in all areas of breast cancer care and quality 
assurance, as well as patients.
Requirements were developed based on reviewing exist-
ing literature, databases and other quality assurance 
schemes internationally. Additionally, new requirements 
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Auditors will assess whether the QA Scheme requirements 
are fulfilled by different means, including remote check-
ing of documents/reports and on-site visits in the breast 
cancer services, the review of medical records, interviews 
with service staff, etc.
Breast cancer services can also follow the QA Scheme 
requirements to improve their current performance, with-
out seeking certification, or in view to obtain it later on.
Services that outsource certain processes can also be 
certified. In these circumstances, legal agreements must 
be in place, and all outsourced processes have to comply 
with the requirements of the QA Scheme. 
To demonstrate compliance, breast cancer services will be 
audited. Auditing is carried out by independent certifica-
tion bodies accredited by National Accreditation Bodies. 
Accreditation ensures that all bodies can perform harmo-
nised independent audits, across borders if required. It is 
envisaged therefore that the QA Scheme will follow ISO/
IEC/17065 for accrediting certification bodies.
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QA SCHEME MANUALS 
Manuals have been developed for each main actor involved in the scheme implementation process. These 
manuals are freely available on the website. 
•  Manual for breast cancer services
All requirements are listed and described in this manual. It provides details on how to meet the respective 
requirements, as well as on the calculation of indicators that will be used to verify quantitative requirements. 
The manual also specifies how compliance with a given requirement has to be demonstrated by the breast 
cancer services. 
•  Scheme owner manual
This manual sets out how the QA Scheme is organised, managed and maintained and how the certification 
process is carried out. The aim is to provide full details of scheme owner requirements for breast cancer 
services and certification bodies participating in the scheme. 
•  Manual for certification bodies
A section of the scheme owner manual is dedicated to certification bodies. This document contains everything 
auditors need to know in terms of scheme requirements, how to perform the audit, and when to give certification. 
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ADDITIONAL TOOLS  
SUPPORTING 
IMPLEMENTATION 
KEY FEATURES
• Support implementation of the European 
Guidelines and the QA Scheme
• Freely available online
• Can be used independent of certification
Additional resources are available to support implementa-
tion of the ECIBC. All these are also freely accessible on the 
ECIBC website and serve a variety of functions. 
These tools complement both the European Guidelines 
and the QA Scheme, and can also be independently used 
to monitor and improve the quality of breast cancer care.  
EUROPEAN GUIDELINES 
Decision support tools
In order to empower women to participate in the decision 
about what intervention is best, decision aids will be made 
available. They will provide information about the possible 
options women have and the consequences of each of 
those options, helping them to reach an informed decision 
which takes into account their personal values and risks.
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Quality indicators calculator
A calculator is available to help breast cancer services to 
compute indicators in a standardised manner, to meas-
ure compliance with the QA Scheme developed by ECIBC. 
Services not looking for certification can also use the tool 
to assess or improve their current performance. 
Population-based screening indicators 
A number of indicators to evaluate the effectiveness of 
population-based organised screening programmes have 
been developed. These indicators measure, for example, the 
coverage and participation in the screening programme, the 
number of screen-detected and interval cancers, or time to 
start treatment. 
These indicators were chosen based on a set of criteria that 
include relevance, measurability, accuracy, ethical consid-
erations and understandability. 
QUALITY ASSURANCE SCHEME
Self-assessment tool 
A self-assessment tool will help services to determine the 
preparedness of breast cancer services to comply with the 
requirements of the QA Scheme and to identify what they 
need to do to achieve compliance.
Services can then apply for formal recognition of compli-
ance with the scheme, which will be assessed by independ-
ent bodies recognised by the scheme.
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